|Awarded On||February 15, 2017|
|Title||Using Social Marketing and Mobile School-Based Vaccination Clinics to Increase HPV Vaccination Uptake in High-Risk Geographic Areas|
|Award Mechanism||Evidence-Based Prevention Programs and Services|
|Institution/Organization||The University of Texas Health Science Center at Houston|
|Principal Investigator/Program Director||Paula Cuccaro|
|Cancer Sites||Cervix Uteri, Head and Neck, HPV-related, Penis, Vagina, Vulva|
An estimated 79 million people in the US are infected with Human Papillomavirus (HPV), and 14 million people are newly infected yearly. High-risk HPV types cause 70% of cervical, 85% of anal, 72% of oropharyngeal, and almost half of vaginal, vulvar, and penile cancers; low-risk HPV types cause genital warts. Cervical cancer incidence and mortality are higher for black than white women and for Hispanic than non-Hispanic women.
Vaccination reduces the likelihood of getting HPV-related cancers or genital warts. Since the vaccine was introduced in 2006, vaccine-type HPV prevalence decreased 56% among female youth 14-19 years of age. The Advisory Committee on Immunization Practices (ACIP) r...